CSI, Imaging & Innovation 2017

May 5, 2017

Friday June 30, 2017

Frankfurt, Germany

Main Room of the Congress Center

Parallel Sessions

Seminar: Challenges with TAVI

Moderator: David Hildick-Smith, MD / Nalan Schnelle, MD

Agenda: 10:30-12:40

New standards for assessing neurologic damage in CV clinical trials – Andreas Baumbach, MD

Can we calculate the cost benefit ratio of embolic protection? – Andreas Baumbach, MD

Claret – tbd

Triguard (Keystone)

Azeem Latbib, MD

Emboline – tbd

Bicuspid and heavily calcified aortic valves: Experience with the Venus valve – tbd

Should we worry about transcatheter heart valve durability? – Danny Dvir

Valve in valve implantations: important lessons from bench to bedside – Danny Dvir

The valve has embolized – now what? – tbd

More than mild regulation after TAVI: assessment and management – Antonio Colombo, MD

Management of iliac rupture – Stefan Toggweiler